Reason for request
Inclusion in a new indication: local symptomatic treatment of lower limb spasticity.
Clinical Added Value
|no clinical added value||
On the basis of available data, DYSPORT does not offer any improvement in actual benefit (no IAB, level V) compared with BOTOX in the local symptomatic treatment of lower limb spasticity in children aged 2 years and over.
Évaluation des médicaments